13F-HR filed by RHO CAPITAL PARTNERS INC
RHO CAPITAL PARTNERS INC filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-12, with 7 holding rows worth $1,092,455,000.
- Accession
- 0001420506-21-001051
- Filer
- CIK 1020455
- Filed
- 2021-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 7 entries on the cover page, a total value of $1,092,455,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,092,455,000 with VALUE read as thousands by filing date, 13F file number 028-05883. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CHARGEPOINT HLDGS INC | 15961R105 | COM CL A | 24,142,341 | $838,705,000 | thousands by filing date | |
| ON24 INC | 68339B104 | COM | 3,637,894 | $129,072,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 3,766,666 | $74,279,000 | thousands by filing date | |
| CARA THERAPEUTICS INC | 140755109 | COM | 1,499,058 | $21,392,000 | thousands by filing date | |
| LIVEXLIVE MEDIA INC | 53839L208 | COM NEW | 3,724,137 | $17,578,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 796,458 | $10,816,000 | thousands by filing date | |
| SENSEONICS HLDGS INC | 81727U105 | COM | 159,601 | $613,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-21-001051 | this filing | 2021-08-12 | acceptance time not in the bulk data set |